Pacira BioSciences, Inc.PCRXNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank57
3Y CAGR-2.8%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-2.8%/yr
vs +29.7%/yr prior
Acceleration
-32.6pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 25.39% |
| 2024 | 9.15% |
| 2023 | 5.86% |
| 2022 | 27.68% |
| 2021 | 3.01% |
| 2020 | -3.62% |
| 2019 | 13.27% |
| 2018 | 9.77% |
| 2017 | 5.82% |
| 2016 | 9.76% |